4th Annual One Mind Summit
Hyatt Regency Crystal City
2799 Jefferson Davis Highway
Arlington, Virginia, USA, 22202
Dr. Ramona Hicks, Chief Scientific Officer or Stephen Johnson, Chief Intellectual Property & Policy Officer, One Mind will moderate all sessions.
Themes: Recap from last year. Thinking big and starting small. The evolution of One Mind from solving by funding to solving by developing new models for collaboration for use throughout neuroscience. Report on progress in Gemini.
Gen. Peter ChiarelliChief Executive Officer, One Mind(download presentation)Theme: Patients’ perspectives are valuable and often underutilized in research design and analysis.
Dr. Tony Altar, Assurex HealthMichael EversExecutive Vice President-Marketing and Patient Advocacy, PatientsLikeMe (PLM)Dr. Tom InselDirector, National Institute of Mental Health (NIMH)Col. Rebecca LorraineAdvisor, Ret. USAF, PatientsLikeMe (PLM)Themes: How and why a scientific field moved to a new model & implications for other fields such as migraine
Themes: How and why a scientific field moved to a new model & implications for other fields such as migraine
Theme: How the tools connect to provide an infrastructure for sharing, accessing and analyzing data.
Dr. Paul AvillachAssistant Professor of Pediatrics, Research Associate in Biomedical Informatics, Harvard Medical School & Children’s Hospital BostonDr. Greg FarberDirector of the Office of Technology Development and Coordination, National Institute on Mental Health (NIMH)Dr. Jeff GretheAssociate Director, Center for Research in Biological Systems, University of California, San DiegoMike JarrettFounder and CEO, QuesGen Systems, Inc.Theme: A new way to do research and examples of how this is working and opportunities and challenges that can be generalized to other disease areas.
Shannon ClarkBusiness Development, Palantir Technologies(download presentation)Themes: Coordination and strategies to reduce costs, provide incentives, optimize research design and reproducibility, and accelerate cures. Creating high quality, reproducible data that can be used by industry and the FDA.
Dr. Glenn BraunsteinChief Medical Officer, Pathway GenomicsJames HeywoodCo-Founder, Chairman, PatientsLikeMeAllison KumarMCM Senior Program Manager, Food and Drug Administration (FDA)Dr. Geoffrey LingDirector, BTO, Defense Advanced Research Projects Agency (DARPA)Ted ThompsonChief Executive Officer, Parkinson's Action Network